Policlinic Tandheelkunde

Active

Private limited companyfounded 200620 yrs activeVeemarkt(Kor) 16, 8500 Kortrijk, BelgiumKBO/BCE: BE 0883.488.767

Summary

Policlinic Tandheelkunde has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€597,632) and a net result of -€127,181. Equity is shrinking by ~46.8% per year across the filed fiscal years. Its solvency ranks better than 5% of 2344 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysis Watch Report Compare

Policlinic TandheelkundeActiveChecked score 41/100

Risk analysis Report Compare

Checked score

Score 2025

41 / 100

Weak

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability0=

Solvency0=

Growth32=

Track record100

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

No credit on open account

Liquidity short (current ratio 0.33 against 0.35 in 2024; short-term debt: 174% and cash: 26.6% of total assets), and equity is negative.

Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 86

Relative position

BE, all sectors

reference

Human health activities (NACE 86)

about 87% fewer bankruptcies

← fewer bankruptcies more bankruptcies →

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

-254.9%

Return on assets

-54.2%

Age of the figures

9 mo

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year -€597,632

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

7 d early

2024

2 d early

2023

20 d early

2022

11 d early

2021

3 d early

2020

5 d early

2019

21 d early

← before the deadline after the deadline →

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

26-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

History

Policlinic Tandheelkunde was incorporated on 12 September 2006.¹ The registered office was moved to Kortrijk in 2011.² In 2014 the capital was increased by EUR 70,200 to EUR 88,950.³ The name was changed to Polikliniek Tandheelkunde in 2022.⁴ The board currently has 2 members; Colosseum Dental België has served longest, since 2019.⁵ Total assets fell from EUR 549,568 in 2018 to EUR 234,475 in 2025 and headcount from 5 to 5.2 full-time equivalents.⁶

Go further with this company

How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Is the workforce growing, and do people stay?Employer check

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity

-€597,632▼ 27.0%

2024 · -€470,451

Total assets

€234,475▲ 34.7%

2024 · €174,045

Net result

-€127,181▲ 20.4%

2024 · -€159,862

Working capital

-€273,752▼ 88.2%

2024 · -€145,448

Trend over the years

Chart Table

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before

favourable unfavourable

Line20212022202320242025

Operating result-€159,923▲ 3.1%-€111,610▲ 30.2%-€46,477▲ 58.4%-€144,002▼ 210%-€107,471▲ 25.4%

Net result-€168,460=-€122,885▲ 27.1%-€59,727▲ 51.4%-€159,862▼ 168%-€127,181▲ 20.4%

Equity-€127,977-€250,862▼ 96.0%-€310,589▼ 23.8%-€470,451▼ 51.5%-€597,632▼ 27.0%

Total assets€243,442▼ 26.4%€205,952▼ 15.4%€233,810▲ 13.5%€174,045▼ 25.6%€234,475▲ 34.7%

Debt€371,420▲ 27.9%€456,814▲ 23.0%€544,399▲ 19.2%€644,496▲ 18.4%€832,106▲ 29.1%

Working capital-€14,947-€9,069▲ 39.3%-€10,333▼ 13.9%-€145,448▼ 1,308%-€273,752▼ 88.2%

Staff (FTE)4.7▼ 9.6%4.7=5▲ 6.4%5=5.2▲ 4.0%

Turnover and EBIT margin not published: the abbreviated schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €107,471 in 2025 against €144,002 in 2024; the loss shrinks.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €234,475

42.7%

57.3%

Fixed assets €100,157 ▲ 6.0%

Current assets €134,318 ▲ 68.9%

Key figures and ratios

2025 value · change against 2024

EBITDA

-€75,222▲

2024 · -€113,807

Cash flow

-€94,932▲

2024 · -€129,666

Solvency

-254.9%▲

2024 · -270.3%

Current ratio

0.33▼

2024 · 0.35

Quick ratio

0.24▲

2024 · 0.18

Debt to equity

-1.39▼

2024 · -1.37

ROA

-54.2%▲

2024 · -91.9%

Interest coverage

-3.82▲

2024 · -7.18

Debt ≤ 1 year

€408,070▲

2024 · €224,962

Debt > 1 year

€400,000=

2024 · €400,000

Staff costs

€253,416▲

2024 · €245,065

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Annual accounts

OverviewIncome statement Balance sheet Cash flow

Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines

Balance sheet Code20242025

Assets

Total assets20/58€174,045€234,475▲

Fixed assets21/28€94,532€100,157▲

Tangible fixed assets22/27€84,832€90,457▲

Plant, machinery and equipment23€84,276€90,033▲

Other tangible fixed assets26€555€424▼

Financial fixed assets28€9,700€9,700=

Current assets29/58€79,514€134,318▲

Stocks and contracts in progress3€38,158€36,972▼

Stocks30/36€38,158€36,972▼

Amounts receivable within one year40/41€21,051€29,961▲

Trade receivables40€20,915€29,856▲

Other amounts receivable41€136€105▼

Cash at bank and in hand54/58€15,061€62,403▲

Deferred charges and accrued income490/1€5,244€4,982▼

Equity and liabilities

Total equity and liabilities10/49€174,045€234,475▲

Equity10/15-€470,451-€597,632▼

Contributions10/11€82,700€82,700=

Reserves13€127,209€127,209=

Distributable reserves133€127,209€127,209=

Profit (loss) carried forward14-€680,360-€807,541▼

Amounts payable17/49€644,496€832,106▲

Amounts payable after more than one year17€400,000€400,000=

Other amounts payable178/9€400,000€400,000=

Amounts payable within one year42/48€224,962€408,070▲

Trade debts44€78,329€103,364▲

Suppliers440/4€78,329€103,364▲

Advances received on contracts in progress46€10,377€5,075▼

Taxes, remuneration and social security45€28,893€34,850▲

Taxes450/3€0€1,973▲

Remuneration and social security454/9€28,892€32,878▲

Other amounts payable47/48€107,364€264,781▲

Accrued charges and deferred income492/3€19,534€24,036▲

Income statement Code20242025

Remuneration, social security and pensions62€245,065€253,416▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€30,195€32,249▲

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€2,123

Other operating charges640/8€5,344€4,172▼

Gross operating margin9900€136,602€184,489▲

Operating profit (loss)9901-€144,002-€107,471▲

Financial income75/76B€1€6▲

Recurring financial income75€1€6▲

Financial charges65/66B€15,861€19,716▲

Recurring financial charges65€15,861€19,716▲

Profit (loss) for the period before taxes9903-€159,862-€127,181▲

Profit (loss) for the period9904-€159,862-€127,181▲

Profit (loss) for the period to be appropriated9905-€159,862-€127,181▲

Appropriation of the result

Profit (loss) to be appropriated9906-€680,360-€807,541▼

Profit (loss) brought forward from the previous period14P-€520,498-€680,360▼

Social balance

Average headcount (FTE)90875.05.2▲

The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line	2021	2022	2023	2024	2025	Change
Remuneration, social security and pensions62	€175,981	€194,609	€247,385	€245,065	€253,416	▲ 3.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€25,348	€27,969	€31,753	€30,195	€32,249	▲ 6.8%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4	-	-	-	-	€2,123	-
Other operating charges640/8	€25,966	€3,577	€2,785	€5,344	€4,172	▼ 21.9%
Gross operating margin9900	€67,372	€114,546	€235,445	€136,602	€184,489	▲ 35.1%
Operating profit (loss)9901	-€159,923	-€111,610	-€46,477	-€144,002	-€107,471	▲ 25.4%
Financial income75/76B	€2	€1	€2	€1	€6	▲ 317%
Recurring financial income75	€2	€1	€2	€1	€6	▲ 317%
Financial charges65/66B	€8,539	€11,276	€13,252	€15,861	€19,716	▲ 24.3%
Recurring financial charges65	€8,539	€11,276	€13,252	€15,861	€19,716	▲ 24.3%
Profit (loss) for the period before taxes9903	-€168,460	-€122,885	-€59,727	-€159,862	-€127,181	▲ 20.4%
Profit (loss) for the period9904	-€168,460	-€122,885	-€59,727	-€159,862	-€127,181	▲ 20.4%
Profit (loss) for the period to be appropriated9905	-€168,460	-€122,885	-€59,727	-€159,862	-€127,181	▲ 20.4%

Line	2021	2022	2023	2024	2025	Change
Assets
Total assets20/58	€243,442	€205,952	€233,810	€174,045	€234,475	▲ 34.7%
Fixed assets21/28	€82,283	€73,470	€116,484	€94,532	€100,157	▲ 6.0%
Intangible fixed assets21	€2,451	€1,219	€0	-	-	-
Tangible fixed assets22/27	€72,132	€64,551	€106,784	€84,832	€90,457	▲ 6.6%
Plant, machinery and equipment23	€70,580	€63,526	€106,098	€84,276	€90,033	▲ 6.8%
Furniture and vehicles24	€603	€207	€0	-	-	-
Other tangible fixed assets26	€949	€818	€686	€555	€424	▼ 23.6%
Financial fixed assets28	€7,700	€7,700	€9,700	€9,700	€9,700	=
Current assets29/58	€161,159	€132,482	€117,326	€79,514	€134,318	▲ 68.9%
Stocks and contracts in progress3	€75,103	€66,798	€45,410	€38,158	€36,972	▼ 3.1%
Stocks30/36	€75,103	€66,798	€45,410	€38,158	€36,972	▼ 3.1%
Amounts receivable within one year40/41	€47,349	€23,710	€40,587	€21,051	€29,961	▲ 42.3%
Trade receivables40	€47,349	€23,710	€40,534	€20,915	€29,856	▲ 42.7%
Other amounts receivable41	€0	-	€53	€136	€105	▼ 22.9%
Cash at bank and in hand54/58	€36,333	€41,974	€31,330	€15,061	€62,403	▲ 314%
Deferred charges and accrued income490/1	€2,375	€0	-	€5,244	€4,982	▼ 5.0%
Equity and liabilities
Total equity and liabilities10/49	€243,442	€205,952	€233,810	€174,045	€234,475	▲ 34.7%
Equity10/15	-€127,977	-€250,862	-€310,589	-€470,451	-€597,632	▼ 27.0%
Contributions10/11	€82,700	€82,700	€82,700	€82,700	€82,700	=
Reserves13	€127,209	€127,209	€127,209	€127,209	€127,209	=
Non-distributable reserves130/1	€8,895	€8,895	€0	-	-	-
Reserves not available under the articles1311	€8,895	€8,895	€0	-	-	-
Distributable reserves133	€118,314	€118,314	€127,209	€127,209	€127,209	=
Profit (loss) carried forward14	-€337,887	-€460,771	-€520,498	-€680,360	-€807,541	▼ 18.7%
Amounts payable17/49	€371,420	€456,814	€544,399	€644,496	€832,106	▲ 29.1%
Amounts payable after more than one year17	€180,000	€300,000	€400,000	€400,000	€400,000	=
Other amounts payable178/9	€180,000	€300,000	€400,000	€400,000	€400,000	=
Amounts payable within one year42/48	€176,106	€141,551	€127,659	€224,962	€408,070	▲ 81.4%
Trade debts44	€47,771	€68,093	€95,326	€78,329	€103,364	▲ 32.0%
Suppliers440/4	€47,771	€68,093	€95,326	€78,329	€103,364	▲ 32.0%
Advances received on contracts in progress46	€1,330	€188	€1,469	€10,377	€5,075	▼ 51.1%
Taxes, remuneration and social security45	€22,765	€26,278	€28,388	€28,893	€34,850	▲ 20.6%
Taxes450/3	-	-	€1	€0	€1,973	▲ 1,643,750%
Remuneration and social security454/9	€22,765	€26,278	€28,387	€28,892	€32,878	▲ 13.8%
Other amounts payable47/48	€104,240	€46,991	€2,476	€107,364	€264,781	▲ 147%
Accrued charges and deferred income492/3	€15,313	€15,264	€16,740	€19,534	€24,036	▲ 23.0%

Line	2021	2022	2023	2024	2025	Change
Profit (loss) for the period9904	-€168,460	-€122,885	-€59,727	-€159,862	-€127,181	▲ 20.4%
+ Depreciation and write-downs630	€25,348	€27,969	€31,753	€30,195	€32,249	▲ 6.8%
Operating cash flow (approximation)	-€143,112	-€94,916	-€27,974	-€129,666	-€94,932	▲ 26.8%
Investment in fixed assets (approximation)	-	-€19,156	-€74,767	-€8,243	-€37,874	▼ 359%
Change in cash	-	€5,641	-€10,645	-€16,269	€47,343	▲ 391%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

All 29Financial 1Gazette 18Filings 10

Next filing, fiscal year 2026, expected by 31-07-2027

2026

24-07

NBB filing Annual accounts filed

fiscal year 2025 · abbreviated schema

2025

29-07

NBB filing Annual accounts filed

fiscal year 2024 · abbreviated schema

09-07

State Gazette act Appointment: Moore Audit (statutory auditor)

Permanent representatives: Sam Kwanten and Jarkko Jokinen4 facts ▸

General meeting, 22-06-2024
Auditor appointment, Moore Audit (statutory auditor)
Permanent representative, Sam Kwanten
Permanent representative, Jarkko Jokinen

2024

11-07

NBB filing Annual accounts filed

fiscal year 2023 · abbreviated schema

2023

13-11

State Gazette act Permanent representative: Jarkko Jokinen

Resignation: Patrick Bakker (permanent representative)3 facts ▸

Board meeting, 23-10-2023
Permanent representative, Jarkko Jokinen
Director resignation, Patrick Bakker (permanent representative)

20-07

NBB filing Annual accounts filed

fiscal year 2022 · abbreviated schema

20-04

State Gazette act Resignations: Patrick Bakker (director) and Maarten ter Haar (director)

Appointment: Colosseum Dental België (director) · Permanent representatives: Patrick Bakker, Sam Kwanten and Luc Martens7 facts ▸

General meeting, 16-01-2023
Director resignation, Patrick Bakker (director)
Director resignation, Maarten ter Haar (director)
Director appointment, Colosseum Dental België (director)
Permanent representative, Patrick Bakker
Permanent representative, Sam Kwanten (statutory auditor)
Permanent representative, Luc Martens (statutory auditor)

2022

16-11

State Gazette act Resignations: Raoul Francis Dias (director) and Daniel Fehr (director)

3 facts ▸

General meeting, 29-07-2022
Director resignation, Raoul Francis Dias (director)
Director resignation, Daniel Fehr (director)

14-11

State Gazette act Statutes amendment

Correction · Prior publication3 facts ▸

General meeting, 04-10-2022
Correction, Policlinic Tandheelkunde
Prior publication, 2022-10-12, nummer 22365099

12-10

State Gazette act Statutes amendment · Legal-form change

Reserve release · Name change · Capital6 facts ▸

General meeting, 04-10-2022
Reserve release, Omvorming van de statutair onbeschikbare eigen vermogensrekening in een beschikbare eigen vermogensrekening
Name change, Polikliniek Tandheelkunde
Statutes amendment
Capital
Legal-form change, Besloten vennootschap met beperkte aansprakelijkheid -> Besloten vennootschap

28-07

NBB filing Annual accounts filed

fiscal year 2021 · abbreviated schema

28-02

State Gazette act Appointments: Maarten ter Haar (director) and Patrick Bakker (director)

3 facts ▸

General meeting, 21-01-2022
Director appointment, Maarten ter Haar (director)
Director appointment, Patrick Bakker (director)

Show earlier events

11-01

State Gazette act Resignations: Prophylaxis Participations B.V. (director) and Dentconnect België BV (director)

Appointments: Daniel Fehr (director) and Raoul Dias (director) · Permanent representatives: Chris Cools and Jeroen van der Hamsvoort7 facts ▸

General meeting, 25-11-2021
Director resignation, Prophylaxis Participations B.V. (director)
Director resignation, Dentconnect België BV (director)
Director appointment, Daniel Fehr (director)
Director appointment, Raoul Dias (director)
Permanent representative, Chris Cools
Permanent representative, Jeroen van der Hamsvoort

2021

31-12

Financial Weakest financial yearnet -€168,460

Net result drops to -€168,460, the lowest in the series; recovery starts the following year.

04-08

State Gazette act Reappointment: PKF-VMB BEDRIJFSREVISOREN (statutory auditor)

2 facts ▸

General meeting, 28-06-2021
Auditor reappointment, PKF-VMB BEDRIJFSREVISOREN (statutory auditor)

26-07

NBB filing Annual accounts filed

fiscal year 2020 · abbreviated schema

2020

10-07

NBB filing Annual accounts filed

fiscal year 2019 · abbreviated schema

24-01

State Gazette act Resignation: Jeroen VAN DER HAMSVOORT (manager)

Appointment: Dentconnect België (manager) · Permanent representative: Jeroen VAN DER HAMSVOORT · Mandate compensation5 facts ▸

General meeting, 11-12-2019
Director resignation, Jeroen VAN DER HAMSVOORT (manager)
Director appointment, Dentconnect België (manager)
Permanent representative, Jeroen VAN DER HAMSVOORT
Mandate compensation, Dentconnect België

2019

25-11

State Gazette act Resignations: Bart VAN DER AUWELAER (manager) and CRSG België B.V. (manager)

Appointments: Jeroen VAN DER HAMSVOORT (manager) and Curaeos B.V. (manager) · Permanent representative: Chris COOLS · Mandate compensation8 facts ▸

General meeting, 03-10-2019
Director resignation, Bart VAN DER AUWELAER (manager)
Director resignation, CRSG België B.V. (manager)
Director appointment, Jeroen VAN DER HAMSVOORT (manager)
Director appointment, Curaeos B.V. (manager)
Permanent representative, Chris COOLS (permanent representative)
Mandate compensation, Jeroen VAN DER HAMSVOORT
Mandate compensation, Curaeos B.V.

30-07

NBB filing Annual accounts filed

fiscal year 2018 · abbreviated schema

11-03

State Gazette act Resignation: DCH België B.V. (manager)

3 facts ▸

General meeting, 31-01-2019
Director resignation, DCH België B.V. (manager)
General meeting, 02-11-2018

06-03

State Gazette act Resignation: Jacob Vermeule (permanent representative)

Permanent representative: Bart Borms · Power of attorney4 facts ▸

General meeting, 29-11-2018
Director resignation, Jacob Vermeule (permanent representative)
Permanent representative, Bart Borms
Power of attorney, Allen & Overy LLP

01-03

State Gazette act Appointment: PKF-VMB Bedrijfsrevisoren (statutory auditor)

Permanent representative: Luc Martens3 facts ▸

General meeting, 01-10-2018
Auditor appointment, PKF-VMB Bedrijfsrevisoren (statutory auditor)
Permanent representative, Luc Martens

2018

17-07

State Gazette act Statutes amendment

Power of attorney5 facts ▸

General meeting, 28-06-2018
Statutes amendment
Statutes amendment
Statutes amendment
Power of attorney, VANDELANOTTE ++

19-03

State Gazette act Resignation: Velghe Sofie (statutory manager)

Appointments: CRSG België B.V., DCH België B.V. and Van der Auwelaer, Bart · Permanent representatives: Vermeule, Jacob Adelbertus Cornelis and George, Jerry Mathen · Purpose change14 facts ▸

General meeting, 09-01-2018
Purpose change, De vennootschap heeft tot doel in België en in het buitenland, uitsluitend in eigen naam en voor eigen rekening: a)het opzetten en exploiteren van voorzieningen…
Director resignation, Velghe Sofie (statutory manager)
Statutes amendment
Capital, €88.950
Director appointment, CRSG België B.V. (manager)
Permanent representative, Vermeule, Jacob Adelbertus Cornelis
Director appointment, DCH België B.V. (manager)
Permanent representative, George, Jerry Mathen
Director appointment, Van der Auwelaer, Bart (manager)
Mandate compensation, CRSG België B.V.
Mandate compensation, DCH België B.V.
+2 further facts in this act

05-01

NBB filing Annual accounts filed

fiscal year 2017 · abbreviated schema

2016

08-12

NBB filing Annual accounts filed

fiscal year 2016 · abbreviated schema

2014

22-08

State Gazette act Capital & shares · Statutes amendment

Approval · Capital increase · Dividend7 facts ▸

General meeting, 27-06-2014
Approval, 04-03-2014
Approval, 26-05-2014
Capital increase, €70.200
Statutes amendment
Statutes amendment
Dividend, ontstaat een vordering van de enige vennoot op de vennootschap, tussentijds

2011

14-06

State Gazette act Registered office

Registered-office move2 facts ▸

General meeting, 01-04-2011
Registered-office move, Veemarkt 16 bus 13 te 8500 KORTRIJK

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

18 of 19 acts read

About the unread acts

Of the 19 Belgian State Gazette acts we know for this company, 18 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors

5 directors, last change in 2022

Raoul Dias

Director · since 25-11-2021

Current

Colosseum Dental België

Director · since 30-09-2019 · Private limited company · perm. rep.: Patrick Bakker

Current

Curaeos B.V.

Manager · since 30-09-2019 · Legal entity · perm. rep.: Chris COOLS

Not recently confirmed

Jeroen van der Hamsvoort

Manager · since 30-09-2019

Not recently confirmed

Van der Auwelaer, Bart

Manager · since 09-01-2018

Not recently confirmed

01-09-2022 Colosseum Dental België: Appointed as Director

01-09-2022 Maarten ter Haar: Resigned as Director

01-09-2022 Patrick Bakker: Resigned as Director

29-07-2022 Daniel Fehr: Resigned as Director

29-07-2022 Raoul Francis Dias: Resigned as Director

Full history in the Timeline (23 changes) →See the board, name and seat on a given date →

Not every act has been read: a resignation may be missing here

1 of this company's 19 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.

Location & real-estate footprint

Registered office, Kortrijk · 1 establishment unit since 2006

seat establishment The establishment unit on the map

Ground area

481 m²

Building footprint

295 m²

Volume, LiDAR

2,749 m³

Parcel 34353B0102/00L026, Flanders · tallest building 14.8 m, ±4 floors. Linked by address, not a title deed.

1 establishment unit

Polikliniek Tandheelkunde

Veemarkt(Kor) 16, 8500 KortrijkNACE 85130

since 20062.199.442.435

1 parcel

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
34353B0102/00L026	Flanders	481 m²	1 · 295 m²	14.8 m · 4 fl.

Linked by address, not proof of ownership

Good to know

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor

Moore AuditCurrent

Statutory auditor · represented by Sam Kwanten

22-06-2024 → present

Articles of association

Purpose

A) het opzetten en exploiteren van voorzieningen en organisaties voor de gezondheidszorg waarin medische specialisten onderzoeken en/of behandelingen in het domein van de…

Full purpose

A) het opzetten en exploiteren van voorzieningen en organisaties voor de gezondheidszorg waarin medische specialisten onderzoeken en/of behandelingen in het domein van de tandheelkunde hun activiteiten kunnen verrichten... b) het mogelijk maken van het uitoefenen van een tandartsenpraktijk... c) de opzetting en de exploitatie van een tandheelkundige praktijk... De vennootschap heeft eveneens tot voorwerp: a) ...beheren van een onroerend vermogen... b) ...beheren van een roerend vermogen... c) ...aangaan en verstrekken van leningen...

according to the deed of 12-10-2022

Structure & network

Connections & network

5 connected companies

Depth

Shared directors

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Linked via shared directors

Aldental

Shared director

→

ConsTand

Shared director

→

TANDARTSENGROEP BEUTELS

Shared director

→

Tandartspraktijk Kasterlee

Shared director

→

Show 1 more companies with a shared director

TANDHEELKUNDIG CENTRUM

Shared director

→

Capital and shareholders

Capital over the years

12-10-2022 Capital stated in the act · 1,000 shares
19-03-2018 Capital stated in the act · 88,950 EUR · 1,000 shares
22-08-2014 Capital increase of 70,200 EUR · to 88,950 EUR · in kind

Similar companies · same sector, comparable size

TANDARTS RUTH BUYSE

BE 0739.562.147

Zwevegem · Eq €40,477

Orthodontie Van de Velde-Kuppens

Koekelare · Eq €40,613

Tandarts Anne Geiregat

BE 0760.993.803

Roeselare · Eq €40,308

Of 6,944 companies in sector 86230 we hold annual accounts for 4,293. 2,894 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification

Legal formPrivate limited company

Founded12-09-2006

Fiscal year end31-12

Activities, NACEBEL 2025

86230Dental practice

Scores and ratios are computed by Checked and are not a credit decision.